Research output per year
Research output per year
Fingerprint
Dive into the research topics where Waldman Department of Dermatology is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
Research output
-
Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
Lebwohl, M. G., Lain, E. L., McMichael, A., Senna, M. M. & Mesinkovska, N. A., Mar 2026, In: JAAD Reviews. 7, p. 1-8 8 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
Relative survival analysis of Merkel cell carcinoma across intersectional demographics using the Surveillance, Epidemiology, and End Results (SEER) database
Hu, B. D., Block, B. R., Rabinowitz, G., Lambert, R., Zhu, A., Verma, H., Jónasson, J. G., Sigurgeirsson, B., Meehan, S., Ungar, J., Lewin, J. M., Gulati, N. & Adalsteinsson, J. A., Feb 2026, In: JAAD International. 24, p. 126-128 3 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Unveiling regions associated with acute and late breast side-effects from breast radiotherapy using voxel-wise image-based data mining analysis
Jaikuna, T., Wilson, F., Anandadas, C., Azria, D., Chang-Claude, J., De Santis, M. C., Gutiérrez-Enríquez, S., van Herk, M., Hoskin, P., Kotzki, L., Lambrecht, M., Lingard, Z., Seibold, P., Seoane, A., Sperk, E., Symonds, R. P., Talbot, C. J., Rancati, T., Rattay, T. & Reyes, V. & 8 others, , Jan 2026, In: Radiotherapy and Oncology. 214, 111230.Research output: Contribution to journal › Article › peer-review
-
A basophil-fibroblast pro-inflammatory axis fuels type 2 skin inflammation
Imanishi, I., Gill, R., Wilder, A., Restrepo, P., Nair, A., Cho, I., Krueger, J. G., Guttman-Yassky, E., Kim, B. S. & Ji, A. L., 26 Aug 2025, In: Cell Reports. 44, 8, 116114.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
A call to action: The need to update population descriptors in dermatology research studies with the use of an inclusive skin classification system
Harvey, V. M., Brown, S. G., Burgess, C. M., Byrd, A. S., Cobb, C. B. C., Desai, S. R., Heath, C. R., Jaleel, T., McMichael, A. J., Miller-Monthrope, Y., Sundaram, H., Takeshita, J., Taylor, S. C., Weiss, J. S., Yoo, J. & Callender, V. D., Aug 2025, In: Journal of the American Academy of Dermatology. 93, 2, p. 553-556 4 p.Research output: Contribution to journal › Article › peer-review
-
A call to action regarding the Risk Evaluation and Mitigation Strategy program for brodalumab
Shah, M. & Lebwohl, M., May 2025, In: Journal of the American Academy of Dermatology. 92, 5, p. 1167-1169 3 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
A case series of dupilumab for vitiligo and alopecia areata in the setting of atopic dermatitis
Patel, D., Hu, B., Alani, O. & Silverberg, N., Oct 2025, In: JAAD Case Reports. 64, p. 46-49 4 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Access to dermatologic care for cancer patients: employment of an oncodermatology referral system
Powers, C. M., Hu, B. D., Block, B. R., Piontkowski, A. J., Silver, C., Orloff, J., Young, J. N., Smith, C. B., Lamb, A. J. & Gulati, N., Mar 2025, In: Supportive Care in Cancer. 33, 3, 161.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Achieving Depth of Response in Skin Clearance and Itch Relief With Lebrikizumab is Associated With Minimal Impact of Atopic Dermatitis on Quality of Life
Chovatiya, R., Simpson, E., Biedermann, T., Kircik, L., Shi, V. Y., Figueras-Nart, I., Casillas, M., Gallo, G., Ding, Y., Zhang, H., Pierce, E., Agell, H. & Vestergaard, C., Jan 2025, In: SKIN: Journal of Cutaneous Medicine. 9, 1, p. s516Research output: Contribution to journal › Article › peer-review
Open Access -
A comparison of large language model powered search tools reveals differences in output quality, information transparency and accessibility for Mohs micrographic surgery enquiries
Jairath, N. K., Chennareddy, S., Manduca, S., Lopez, A., Alam, M., Golda, N., Ng, E., Patel, V. A., Ruiz, E. S., Trufant, J. W. & Lewin, J. M., 1 Jun 2025, In: Clinical and Experimental Dermatology. 50, 6, p. 1244-1245 2 p.Research output: Contribution to journal › Letter › peer-review
1 Scopus citations -
Aesthetic Efficacy and Safety of Combined Microfocused Ultrasound with Visualization and Calcium Hydroxylapatite Treatment: A Systematic Review of Human Evidence
Amiri, M., Meçani, R., Niehot, C. D., Muharremi, G., Spada, J., Vasconcelos, R., Pavicic, T., Sattler, S., Levin, M. K., Tuck Wah, S., Carroll, J., Cook, S. & Muka, T., 1 Jun 2025, In: Aesthetic Surgery Journal. 45, 6, p. 638-642 5 p.Research output: Contribution to journal › Review article › peer-review
Open Access2 Scopus citations -
Age-stratified analysis of health-related quality of life in patients with early-stage breast cancer receiving adjuvant radiation therapy and endocrine therapy
on behalf of the REQUITE consortium, Mar 2025, In: Journal of Geriatric Oncology. 16, 2, 102195.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations
Press/Media
-
Weekly Summary: Apogee Therapeutics (APGE: $38.14) in bottom 2% performers of NASDAQ market in past week; -$9.32 [19.6%] Vol Index 4.2 [1 is avg]
12/07/25
1 item of Media coverage
Press/Media
-
Pelthos Therapeutics Launches ZELSUVMI (berdazimer) Topical Gel 10.3%, the First and Only FDA-Approved At-Home Treatment for Molluscum Contagiosum
10/07/25 → 11/07/25
3 items of Media coverage
Press/Media
-
Pelthos Therapeutics Launches ZELSUVMITM (Berdazimer) Topical Gel 10.3%, The First And Only FDA-Approved At-Home Treatment For Molluscum Contagiosum
10/07/25 → 11/07/25
11 items of Media coverage
Press/Media
-
-
-
The 'robot doctor' operates alone, first surgery without human help
9/07/25
1 item of Media coverage
Press/Media
-
Why we itch: An interview with Brian S. Kim, MD
Lebwohl, M., Perelman, , S. & Kim, B.
8/07/25
1 item of Media coverage
Press/Media
-
Itch is different from pain, research shows
Lebwohl, M., Perelman, , S. & Kim, B.
8/07/25
1 item of Media coverage
Press/Media
-
Apogee Therapeutics Announces Positive 16-Week Data From Phase 2 APEX Clinical Trial Of APG777, Its Potentially Best-In-Class Anti-IL-13 Antibody, In Moderate-To-Severe Atopic Dermatitis
7/07/25 → 8/07/25
27 items of Media coverage
Press/Media